AU  - Giuliano V
FAU  - Giuliano, Vanessa
AU  - Chan S
FAU  - Chan, Sze Wah Samuel
TI  - Subcutaneous amivantamab with lazertinib is non-inferior to intravenous administration, with fewer adverse reactions
PT  - BOOK SECTION
DP  - 2015
BTI  - 2 Minute Medicine
DA  - 2015
Y2  - 2024/10/08
UR  - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=649041